Literature DB >> 15451997

Cost-effectiveness and evidence evaluation as criteria for coverage policy.

Alan M Garber1.   

Abstract

Private health plans and government health insurance programs in the United States base their coverage decisions on evidence criteria, rather than explicit cost-effectiveness criteria. As health spending continues to grow rapidly, however, approaches to coverage policy that ignore costs fail to meet the needs of consumers, employers, health plans, and federal and state governments. I describe the role of evidence-based criteria in formal coverage decision making and contrast the ways that these criteria differ from cost-effectiveness criteria. Finally, I discuss options for incorporating considerations of cost-effectiveness into coverage policy and other aspects of benefit design.

Mesh:

Year:  2004        PMID: 15451997     DOI: 10.1377/hlthaff.w4.284

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  17 in total

1.  Anal Cancer Screening for HIV-Negative Men Who Have Sex with Men: Making Clinical Decisions with Limited Data.

Authors:  Michael A Fuchs; Ami G Multani; Kenneth H Mayer; Alex S Keuroghlian
Journal:  LGBT Health       Date:  2021-05-24       Impact factor: 4.151

Review 2.  Economic evaluation in the US: what is the missing link?

Authors:  Peter J Neumann; Sean D Sullivan
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  Reform of prescription drug reimbursement and pricing in the German social health insurance market: a comparison of three scenarios.

Authors:  Stefan Gress; Dea Niebuhr; Uwe May; Jürgen Wasem
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 4.  Challenges of translating genetic tests into clinical and public health practice.

Authors:  Wolf H Rogowski; Scott D Grosse; Muin J Khoury
Journal:  Nat Rev Genet       Date:  2009-07       Impact factor: 53.242

5.  Criteria for fairly allocating scarce health-care resources to genetic tests: which matter most?

Authors:  Wolf H Rogowski; Scott D Grosse; Jörg Schmidtke; Georg Marckmann
Journal:  Eur J Hum Genet       Date:  2013-08-07       Impact factor: 4.246

6.  Cost-effectiveness of smoking cessation programs for hospitalized patients: a systematic review.

Authors:  Donghoon Lee; Ye-Rin Lee; In-Hwan Oh
Journal:  Eur J Health Econ       Date:  2019-08-26

7.  Transatlantic convergence with respect to the fourth hurdle?

Authors:  Joshua Cohen
Journal:  Pharmacoeconomics       Date:  2006-12       Impact factor: 4.981

8.  Paying for prevention: challenges to health insurance coverage for biomedical HIV prevention in the United States.

Authors:  Kristen Underhill
Journal:  Am J Law Med       Date:  2012

9.  Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia.

Authors:  Sonya J Snedecor; Marc F Botteman; Chris Bojke; Kendyl Schaefer; Nadine Barry; A Simon Pickard
Journal:  Sleep       Date:  2009-06       Impact factor: 5.849

Review 10.  Economic Evaluations in National Cancer Institute-Sponsored Network Cancer Clinical Trials.

Authors:  Van T Nghiem; Riha Vaidya; Gary H Lyman; Dawn L Hershman; Scott D Ramsey; Joseph M Unger
Journal:  Value Health       Date:  2020-10-09       Impact factor: 5.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.